To demonstrate the feasibility of probing rHER2 in vivo, HER2 tumor-bearing mice were either treated with the highest histotripsy dose from the previous experiments (HT) or untreated controls (UH) (Figure 11). Here, ERBB2 is linked to neoplasm.